We have used quantitative autoradiographic techniques to study the relationship between cerebral blood flow (CBF) and glucose utilization (CGU) in two lines of transgenic mice overexpressing Swedish mutant amyloid precursor protein (APP) and APP-derived A␤ peptides. Mice were studied at an age when there are no amyloid plaques. In the 2123 line, CBF was reduced only in telencephalic regions with no corresponding decrease in CGU. In 2576 transgenics, a line with higher levels of A␤ peptide, both CBF and CGU were reduced throughout the brain. The data indicate that A␤ induces alterations in resting CBF that are either associated with or independent of alterations in CGU and that occur in the absence of amyloid deposition in neuropil of blood vessels. These observations support the hypothesis that cerebrovascular and metabolic abnormalities are early events in the pathogenesis of Alzheimer's disease. © 2002 Elsevier Science (USA)
INTRODUCTION
Alzheimer's disease (AD) is the most common cause of dementia in the elderly and is characterized neuropathologically by amyloid plaques and neurofibrillary tangles (see Selkoe, 2001 , for a review). The amyloid precursor protein (APP) has emerged as a critical factor in the molecular pathology of AD. Mutations in APP are linked to familial forms of AD (ChartierHarlin et al., 1991; Goate et al., 1991; Mullan et al., 1992; see Levy-Lahad and Bird, 1996 , for a review), and peptides derived from the processing of APP by secretases are major constituents of the amyloid plaque (Glenner and Wong, 1984; see Mattson, 1997 , for a review). Furthermore, overexpression of APP in transgenic mice produces neuropathological and/or behavioral alterations resembling those of AD (Games et al., 1995; Hsiao et al., 1996 Hsiao et al., , 1995 . Therefore, abnormalities in APP processing resulting in A␤ accumulation are thought to be important steps in the pathogenesis of AD (Selkoe, 2001 ).
It has long been known that patients with AD have morphological and functional alterations of the cerebral circulation (see Kalaria, 1996, and Friedland, 1990 , for reviews). While cerebral microvessels have pronounced morphological abnormalities (Fischer et al., 1990; Kalaria and Hedera, 1995; Kidd, 1964; Scheibel and Duong, 1988; Stewart et al., 1992) , CBF and/or CGU are reduced in patients with AD (Jagust et al., 1998; Prohovnik et al., 1988; Reiman et al., 1996; Small et al., 2000) . However, it has been difficult to assess the significance of these cerebrovascular changes because the alterations in resting CBF and CGU could be secondary to the amyloid deposition and related neuronal dysfunction that accompany AD.
In the present study, we measured resting CBF and CGU in transgenic mice overexpressing APP (Hsiao et al., 1996 (Hsiao et al., , 1995 to determine whether APP overexpression and A␤ are able to induce alterations in CBF and CGU in the absence of amyloid plaques. We found that APP mice, at an age when they do not exhibit amyloid plaques or neurodegeneration (Hsiao et al., 
